New drug combo shows promise for slowing kidney disease
Disease control
Completed
This study tested whether adding a new medication called sparsentan could help adults with IgA nephropathy (IgAN), a kidney disease, when they were already taking standard treatments. Researchers followed 48 participants for 28 weeks to see if the combination was safe and could r…
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC